HOLX - Hologic shares up 3.75% on surprise revenue estimates ahead of Q1 results

Hologic ([[HOLX]] +3.4%) moves up after the company released its Q1 prelim revenue estimate much above its guidance and market expectations.Healthcare equipment company says it expects Q1 total revenues of ~$1.61B (+89.3% Y/Y), compared to its most recent guidance range of $1.35-$1.43B, and vs. consensus of $1.39B.Break-down of the company's global estimated revenue by division: Hologic also expects its Non-GAAP EPS to be significantly higher than its guidance of $2.10 - $2.25, as provided on Nov. 4, 2020.GAAP EPS is expected to be $1.88 - $2.03."Hologic’s strong momentum continued in the first quarter of fiscal 2021 as organic revenue more than doubled, well ahead of our prior expectations. Importantly as well, our Breast Health and Surgical businesses showed remarkable strength, with each franchise posting growth in all major geographies – the United States, Europe and Asia-Pacific," says Chairman, President and CEO Steve MacMillan.Hologic's full Q1 results are scheduled for release on Jan. 27, 2021.Previously (Jan. 7): Life Science Tools &

For further details see:

Hologic shares up 3.75% on surprise revenue estimates ahead of Q1 results